Safety and Efficacy of Rituximab and Cyclophosphamide in a Case of Resistant Acquired Hemophilia A in Course of Chronic Lymphocytic Leukemia

Acquired Hemophilia A (AHA) is a rare disease caused by anti-factor VIII autoantibodies. It is usually characterized by clinically significant bleeding at the onset and requires prompt hemostatic and immunosuppressive therapies. Due to its rarity and the lack of randomized trials, its treatment is a...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cureus
Asıl Yazarlar: Mazziotta, Francesco, Cecconi, Nadia, Iovino, Lorenzo, Cervetti, Giulia, Petrini, Mario
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Cureus 2019
Konular:
Allergy/Immunology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6822901/
https://ncbi.nlm.nih.gov/pubmed/31700733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.5630
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller